神田忠仁 (Tadahito Kanda) - マイポータル

基本情報

所属: 厚生労働省国立感染症研究所病原体ゲノム解析研究センターセンター長

学位: 医学博士(東京大学)

J-GLOBAL ID: 200901077822412310
researchmap会員ID: 0000020497

外部リンク: http://www.nih.go.jp

研究キーワード

研究分野

ライフサイエンス / ウイルス学 /

経歴

1992年

(1992, Chief of Division of Molecular Genetics)
1985年

- 国立感染研（旧予研）研究員
1985年

- Researcher in National Institute of Infectious
1980年 - 1984年

Research Assistant in Institute of Medical
1980年

−1984 東大医科研助手
Diseases
Science, Tokyo University

委員歴

日本遺伝子治療学会, 評議員

MISC

117

Kawana, K., Yasugi, T., Kanda, T., Kawana, Y., Hirai, Y., Yoshikawa, H., Taketani, Y.: Neutralizing antibodies against oncogenic human papillomavirus (HPV) as a possible determinant of the fate of low-grade cervical intraepithelial neoplasia.

KAWANA K, YASUGI T, KANDA T, KAWANA Y, HIRAI Y, YOSHIKAWA H, TAKETANI Y

BBRC 296(1) 102-105 2002年
Mori, S., Murakami, M., Takeuchi, T., and Kozuka, T., Kanda, T., : Rescue of AAV by sntibody-Induced Fas-Mediated Apoptosis from Viral DNA Integrated in HeLa Chromosome.

Virology, 301:90-98, 2002.
Kawana, k., Yasugi, T., Kanda, T., Kawana, Y., Hirai, Y., Yoshikawa, H., Taketani, Y., : Neutralizing Antibodies against Oncogenic Human Papillomavirus (HPV) as a Possible Determinant of the Fate of Low-Grade Cervical Intraepithelial Neoplasia.

BBRC, 296:102-105, 2002.
Matsumoto, K., Yoshikawa, H., Yasugi, T., Nakagawa, S., Kawana, K., Takeoka, A., Yaegashi, N., Iwasaka, T., Kanazawa, K., Taketani, Y., and Kanda, T., : IgG Anitibodies to Human Papillomavirus 16, 52, 58 and 6 Li-Capsids: a Case-Control Study of Cervic・・・

J. Medical Virology, in Press, 2002.
Ishii, Y., Tanaka, K., and Kanda, T. : Mutational Analysis of Human Papillomavirus Type 16 Major Capsid Protein L1 : the Cysteines Affecting the Intermolecular Bonding and Structure of L1-Capsids.

Virology, in Press 2002.
Matsumoto,K.,Yoshikawa,H.,Nakagawa,S.,Tang,X.,Yasugi,T., Kawana,K.,Sekiya,S.,Hirai,Y.,Kukimoto,I.,Kanda,T., and Taketani,Y.: Enhanced oncogenicity of human papillomavirus type 16(HPV16)variants in Japanese population.

Cancer Letter,2000
Kawana,K.,Kawana,Y.,Yoshikawa,H.,Taketani,Y.,Yoshiike,K., and Kanda,T.: Nasal Immunization of Mice with Peptide Having a Cross-Neutralization Epitope on Minor Capsid Protein L2 of Human Papillomavirus Type 16 Elicit Systemic and Mucosal Antibodies.

Vaccine,19:1496-1502,2001.
Kawana,Y.,Kawana,K.,Yoshikawa,H.,Taketani,Y.,Yoshiike,K., and Kanda,T.: Human Papillomavirus 16 Minor Capsid Protein L2 N-terminal Region Containing a Common Neutralization Epitope Binds to the Cell Surface and Enters the Cytoplasm.

J. Virol.75:2331-1336,2001.
Igaki,H.,Nakagawa,K.,Aoki,Y.,Ohtomo,K.,Kukimoto,I., and Kanda,T.: Characterization of the Bi-directional Transcriptional Control Region between the Human UFD1L and CDC45L Genes.

BBRC283,569-576,2001
Kukimoto and Kanda,T.: Displacement of YY1 by Differentiation Specific Transcription Factor hSkn-1a Activates P670 Promoter of Human Papillomavirus Type 16.

J. Virol.75:9302-11,2001
Yajima T., Kanda T. Yoshiike K., and Kitamura Y.: Retroviral vector targeting human cells via c-kit-stem cell factor interaction

Human Gene Therapy 9, 779-787, 1998
Watanabe S., Sato H., Komiyama N., Kanda T. and Yoshiike K. The E7 Functions of Human Papillomavirus in Rat 3Y1 Cells

Virology, 187, 107-114. 1992
Watanabe S., Kanda T. and Yoshiike K. : Human papillomavirus type 16 transformation of primary human embryonic fibroblasts requires expression of open reading frames E6 and E7

J. Virol., 63, 965-969, 1989
Watanabe S., Kanda T. and Yoshiike K. : Growth dependence of human papillomavirus 16 DNA-positive cervical cancer cell lines and human papillomavirus 16-transformed human and rat cells on the viral oncoproteins

Jpn. J. Cancer Res., 84, 1043-1049, 1993
Watanabe S., Kanda T. Sato H., Furuno A., and Yoshiike K. : Mutational analysis of human papillomavirus type 16 E7 functions

J. Virol., 64, 207-214, 1990
Takeuchi T., Kozuka T., Nakagawa K., Aoki Y., Ohtomo K., Yoshiike K., and Kanda T. : Adeno-Associated Virus Type 2 Nonstructural Protein Rep78 Suppresses Translation In Vitro

Virology. 2000, 266, 196-202, 2000
Takemoto K. K., and Kanda T. : Lymphotropic papovavirus transformation of hamster embryo cells

J. Virol., 50, 100-105, 1984
Takagi T., Iwama M., Seta K., Kanda T. Tsukamoto T., Tominaga S., and Mizumoto K. : Positive and negative host factors for Sendai virus transcription and their organ distribution in rat

Archiv Virol. 141, 1623-1635, 1996
Taira H., Kanda T. Omata T., Shibuta H., Kawakita M., and lwasaki K. : Interferon induction by transfection of Sendai virus C gene CDNA

J. Virol., 61, 625-628, 1987
Shioda T., Hidaka Y., Kanda T. Shibuta, H., Nomoto A., and lwasaki K. : Sequence of 3,687 nucleotides from the 3' end of Sendai virus genome RNA and the predicted amino acid sequences of viral NP, P, and C proteins

Nucleic Acids Research, 11, 7317-7330, 1983

もっとみる

所属学協会

共同研究・競争的資金等の研究課題

AAVベクターの開発

厚生労働科学研究費補助金 2002年 - 2010年
3. Development of adeno-associated Viral vectors

Health and Labour Sciences Research Grants 2002年 - 2010年
2. Study on oncogenicity of human papillomaviruses

Basic Research Promotion Service for Health and Medical Field 2002年 - 2010年
1. Development of vaccine for human papillomaviruses

Health and Labour Sciences Research Grants 2001年 - 2010年
HPV増殖機構の解析

保健医療分野における基礎研究推進事業 2000年 - 2010年
HPV予防ワクチンの開発

厚生労働科学研究費補助金 2000年 - 2010年